These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34020062)

  • 1. Differentiation of Primary Central Nervous System Lymphoma and High-Grade Glioma with Dynamic Susceptibility Contrast-Derived Metrics: Pilot Study.
    Chaganti J; Taylor M; Woodford H; Steel T
    World Neurosurg; 2021 Jul; 151():e979-e987. PubMed ID: 34020062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
    Xing Z; You RX; Li J; Liu Y; Cao DR
    Clin Neuroradiol; 2014 Dec; 24(4):329-36. PubMed ID: 23994941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating dynamic susceptibility contrast-enhanced perfusion-weighted magnetic resonance imaging in posterior fossa tumors: differences and similarities with supratentorial tumors.
    Gaudino S; Benenati M; Martucci M; Botto A; Infante A; Marrazzo A; Ramaglia A; Marziali G; Guadalupi P; Colosimo C
    Radiol Med; 2020 Apr; 125(4):416-422. PubMed ID: 31916104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
    Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
    Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percentage signal intensity recovery: A step ahead of rCBV in DSC MR perfusion imaging for the differentiation of common neoplasms of brain.
    Surendra KL; Patwari S; Agrawal S; Chadaga H; Nagadi A
    Indian J Cancer; 2020; 57(1):36-43. PubMed ID: 31898591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of high-grade glioma and primary central nervous system lymphoma: Multiparametric imaging of the enhancing tumor and peritumoral regions based on hybrid
    Zhang S; Wang J; Wang K; Li X; Zhao X; Chen Q; Zhang W; Ai L
    Eur J Radiol; 2022 May; 150():110235. PubMed ID: 35290912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
    Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R
    Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of combined use of DWI and percentage signal recovery-optimized protocol of DSC-MRI in differentiation of high-grade glioma, metastasis, and lymphoma.
    Cindil E; Sendur HN; Cerit MN; Dag N; Erdogan N; Celebi FE; Oner Y; Tali T
    Neuroradiology; 2021 Mar; 63(3):331-342. PubMed ID: 32821962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.
    Kickingereder P; Wiestler B; Sahm F; Heiland S; Roethke M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
    Radiology; 2014 Sep; 272(3):843-50. PubMed ID: 24814181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved performance of non-preloaded and high flip-angle dynamic susceptibility contrast perfusion-weighted imaging sequences in the presurgical differentiation of brain lymphoma and glioblastoma.
    Wang F; Zhou X; Chen R; Kang J; Yang X; Lin J; Liu F; Cao D; Xing Z
    Eur Radiol; 2023 Dec; 33(12):8800-8808. PubMed ID: 37439934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
    Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
    Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric analysis from dynamic susceptibility contrast-enhanced perfusion MRI to evaluate malignant brain tumors.
    Abreu VS; Tarrio J; Silva J; Almeida F; Pinto C; Freitas D; Filipe JP
    J Neuroimaging; 2024; 34(2):257-266. PubMed ID: 38173078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Glioma Localization Diagnosis Based on Magnetic Resonance Imaging.
    Jin Y; Peng H; Peng J
    World Neurosurg; 2021 May; 149():325-332. PubMed ID: 32992057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of arterial spin labelling MRI for discriminating atypical high-grade glioma from primary central nervous system lymphoma.
    Di N; Cheng W; Chen H; Zhai F; Liu Y; Mu X; Chu Z; Lu N; Liu X; Wang B
    Clin Radiol; 2019 Feb; 74(2):165.e1-165.e9. PubMed ID: 30415766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of central lymphoma and high-grade glioma: dynamic contrast-enhanced histogram.
    Zhang HW; Lyu GW; He WJ; Lei Y; Lin F; Feng YN; Wang MZ
    Acta Radiol; 2020 Sep; 61(9):1221-1227. PubMed ID: 31902220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic inflammatory biomarkers in primary central nervous system lymphoma versus high-grade glioma: exploratory, comparative and correlative analysis.
    Gupta T; Nayak P; Baviskar Y; Gupta M; Moiyadi A; Epari S; Janu A; Purandare N; Rangarajan V; Bagal B; Chatterjee A; Sastri GJ
    CNS Oncol; 2022 Jun; 11(2):CNS83. PubMed ID: 35373582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myo-inositol concentration in MR spectroscopy for differentiating high grade glioma from primary central nervous system lymphoma.
    Nagashima H; Sasayama T; Tanaka K; Kyotani K; Sato N; Maeyama M; Kohta M; Sakata J; Yamamoto Y; Hosoda K; Itoh T; Sasaki R; Kohmura E
    J Neurooncol; 2018 Jan; 136(2):317-326. PubMed ID: 29143277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient.
    Bao S; Watanabe Y; Takahashi H; Tanaka H; Arisawa A; Matsuo C; Wu R; Fujimoto Y; Tomiyama N
    Magn Reson Med Sci; 2019 Jan; 18(1):53-61. PubMed ID: 29848919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of Susceptibility-Weighted Imaging and Dynamic Susceptibility Contrast Magnetic Resonance Imaging for Differentiating High-Grade Glioma from Primary Central Nervous System Lymphomas: Meta-Analysis.
    Wu Y; Den Z; Lin Y
    World Neurosurg; 2018 Apr; 112():e617-e623. PubMed ID: 29371168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.
    Hu LS; Baxter LC; Smith KA; Feuerstein BG; Karis JP; Eschbacher JM; Coons SW; Nakaji P; Yeh RF; Debbins J; Heiserman JE
    AJNR Am J Neuroradiol; 2009 Mar; 30(3):552-8. PubMed ID: 19056837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.